A MicroRNA Network Controls Legionella pneumophila Replication in Human Macrophages via LGALS8 and MX1

Christina E Herkt1, Brian E Caffrey2, Kristin Surmann3

  • 1Institute for Lung Research, Universities of Giessen and Marburg Lung Center, Philipps University Marburg, Marburg, Germany.

Mbio
|March 27, 2020
PubMed

Insights

Three microRNAs (miRNAs) control Legionella pneumophila replication in human macrophages. These miRNAs downregulate key immune genes, forming a network that restricts bacterial growth and offers new therapeutic targets for Legionella pneumonia.

Area of Science:

  • Immunology
  • Microbiology
  • Molecular Biology

Background:

  • Legionella pneumophila causes pneumonia by invading macrophages and manipulating host defenses.
  • MicroRNAs (miRNAs) are crucial regulators of gene expression involved in host defense against bacterial infections.
  • Pathogens can exploit host miRNA machinery for their own benefit.

Purpose of the Study:

  • To investigate the role of macrophage miRNAs in controlling intracellular Legionella pneumophila replication.
  • To identify specific miRNAs and their target genes involved in the host immune response to L. pneumophila.

Main Methods:

  • Analysis of miRNA expression changes in human macrophages infected with L. pneumophila.
  • Chromatin immunoprecipitation and sequencing to assess histone acetylation at miRNA promoters.
  • Proteome analysis to identify target genes regulated by identified miRNAs.

Main Results:

  • Significant regulation of 85 miRNAs was observed in human macrophages upon L. pneumophila infection.
  • A specific set of three miRNAs (miR-125b, miR-221, and miR-579) cooperatively inhibited L. pneumophila replication.
  • These miRNAs collectively downregulate key immune-related genes: galectin-8 (LGALS8), DDX58, TP53, and MX1.

Conclusions:

  • A novel miRNA-controlled immune network restricts Legionella replication in human macrophages.
  • This network involves three miRNAs regulating crucial immune factors, offering new insights into host defense mechanisms.
  • The identified miRNA-gene network presents potential therapeutic targets for treating Legionella infections.